NASDAQ: LGVNLongeveron Inc Stock Ownership - Who owns Longeveron?
Insider buying vs selling
Have Longeveron Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mohamed Wael Ahmed Hashad | Chief Executive Officer | 2025-07-01 | 13,146 | $1.28 | $16.83kSell |
| Nataliya Agafonova | Chief Medical Officer | 2025-07-01 | 7,431 | $1.28 | $9.51kSell |
| Lisa Locklear | Chief Financial Officer | 2025-07-01 | 7,431 | $1.28 | $9.51kSell |
| Devin Blass | CTO SVP of CMC | 2025-07-01 | 4,599 | $1.28 | $5.89kSell |
| Paul T. Lehr | General Counsel Secretary | 2025-07-01 | 1,562 | $1.28 | $2.00kSell |
| Paul T. Lehr | General Counsel Secretary | 2025-06-23 | 64,158 | $1.15 | $73.78kSell |
| Rock Soffer | Director | 2025-05-30 | 11,000 | $1.25 | $13.75kSell |
| Rock Soffer | Director | 2025-05-29 | 10,000 | $1.30 | $13.00kSell |
| Rock Soffer | Director | 2025-05-22 | 2,000 | $1.32 | $2.64kSell |
| Joshua Hare | Chief Scientific Officer | 2025-05-16 | 5,250 | $1.40 | $7.37kSell |
LGVN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when LGVN insiders and whales buy or sell their stock.
LGVN Shareholders
What type of owners hold Longeveron Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Donald M. Soffer | 91.40% | 13,717,945 | $19.48M | Insider |
| Joshua Hare | 5.17% | 775,310 | $1.10M | Insider |
| Paul T. Lehr | 1.69% | 254,073 | $360.78k | Insider |
| Mohamed Wael Ahmed Hashad | 1.61% | 240,904 | $342.08k | Insider |
| Rock Soffer | 1.39% | 209,034 | $296.83k | Insider |
| Vanguard Group Inc | 0.96% | 144,272 | $204.87k | Institution |
| Geode Capital Management LLC | 0.94% | 140,731 | $199.84k | Institution |
| Lisa Locklear | 0.91% | 137,198 | $194.82k | Insider |
| Nataliya Agafonova | 0.91% | 136,697 | $194.11k | Insider |
| Geoff Green | 0.89% | 133,904 | $190.14k | Insider |
LGVN vs Biotech Stocks
Longeveron Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.